Renaissance Technologies’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.8K | Buy |
98,311
+4,100
| +4% | +$1.58K | ﹤0.01% | 3423 |
|
|
2025
Q1 | $98K | Buy |
94,211
+17,300
| +22% | +$18K | ﹤0.01% | 3201 |
|
|
2024
Q4 | $75.1K | Sell |
76,911
-16,759
| -18% | -$16.4K | ﹤0.01% | 3326 |
|
|
2024
Q3 | $138K | Buy |
93,670
+29,088
| +45% | +$42.8K | ﹤0.01% | 3201 |
|
|
2024
Q2 | $87.2K | Sell |
64,582
-42,359
| -40% | -$57.2K | ﹤0.01% | 3208 |
|
|
2024
Q1 | $175K | Buy |
106,941
+68,770
| +180% | +$113K | ﹤0.01% | 3258 |
|
|
2023
Q4 | $74K | Sell |
38,171
-200
| -0.5% | -$388 | ﹤0.01% | 3378 |
|
|
2023
Q3 | $92K | Sell |
38,371
-4,100
| -10% | -$9.83K | ﹤0.01% | 3268 |
|
|
2023
Q2 | $108K | Sell |
42,471
-35,000
| -45% | -$89K | ﹤0.01% | 3453 |
|
|
2023
Q1 | $126K | Sell |
77,471
-13,700
| -15% | -$22.3K | ﹤0.01% | 3420 |
|
|
2022
Q4 | $250K | Sell |
91,171
-67,066
| -42% | -$184K | ﹤0.01% | 3319 |
|
|
2022
Q3 | $625K | Buy |
158,237
+62,465
| +65% | +$247K | ﹤0.01% | 2789 |
|
|
2022
Q2 | $540K | Buy |
95,772
+5,100
| +6% | +$28.8K | ﹤0.01% | 3122 |
|
|
2022
Q1 | $1.02M | Sell |
90,672
-17,098
| -16% | -$192K | ﹤0.01% | 2719 |
|
|
2021
Q4 | $1.57M | Buy |
107,770
+43,700
| +68% | +$638K | ﹤0.01% | 2341 |
|
|
2021
Q3 | $1.92M | Buy |
64,070
+12,810
| +25% | +$384K | ﹤0.01% | 2121 |
|
|
2021
Q2 | $2.38M | Buy |
+51,260
| New | +$2.38M | ﹤0.01% | 2145 |
|
|
2020
Q3 | – | Sell |
-28,090
| Closed | -$2.44M | – | 3697 |
|
|
2020
Q2 | $2.44M | Buy |
28,090
+13,650
| +95% | +$1.18M | ﹤0.01% | 2083 |
|
|
2020
Q1 | $838K | Buy |
14,440
+11,440
| +381% | +$664K | ﹤0.01% | 2509 |
|
|
2019
Q4 | $216K | Buy |
+3,000
| New | +$216K | ﹤0.01% | 3178 |
|